S-488410
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S-488410, covering 2015-08-13 to 2015-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer [Phase 2]